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Introduction
Human central neurocyotoma was first described as one of the benign tumors usually found in the anterior region of lateral ventricles in the brain (Hassoun et al., 1982) . Central neurocytomas are composed of uniform round shaped cells with central nuclei and a perinuclear halo (Hassoun et al., 1993) . For a long time, neurocytomas were originally believed to be a kind of oligodendroglioma or ependymal glioma due to morphological resemblances to oligodendrocytes and ependymal cells (Hassoun et al., 1982) . However, recent reports have shown that neurocytomas are genetically different from oligodendrogliomas and neuroblastomas (Tong et al., 2000) .
Several histological studies found expression of neuron-specific enolase (NSE) (Von Deimling et al., 1990; Kubota et al., 1991; Kim et al., 1992) and synaptophysin (Von Deimling et al., 1990; Kim et al., 1992; Ishiuchi and Tamura, 1997) in neurocytomas freshly isolated from the patients. Thus, it is widely accepted that neurocytomas have neuronal characteristics. Interestingly, glial fibrillary acidic protein (GFAP) has been also found in neurocytomas (Von Deimling et al., 1990 Deimling et al., , 1991 Ishiuchi and Tamura, 1997) . The GFAP expression was originally believed to be due to reactive astrocytes located in freshly isolated neurocytomas (Kubota et al., 1991; Figarella-Branger et al., 1992) as well as in cultured neurocytoma cells (Westphal et al., 1994; Westphal et al., 1998) . Thus, it remains to be determined whether the cells in neurocytomas have a potential to differentiate into both neurons and astrocytes, or neurocytomas are mixtures of neurons and glial cells.
In this study, we investigated proliferation properties and the expression level of nestin, a well known neural stem cell marker in neurocytomas to determine the multipotency of neurocytoma cells isolated from Korean patients. We found that the activation of protein kinase A (PKA) signaling pathway with forskolin induces astroglial differentiation of neurocytoma cells.
M aterials and M ethods C ell culture
Human central neurocytoma were diagnosed as described previously (Paek et al., 2003) and isolated from two Korean patients who underwent craniotomy cell were for lateral ventricle tumors. Cultured in DMEM/ Forskolin prom otes astroglial differentiation of hum an central neurocytom a cells F12 (1:1) containing 2% fetal bovine serum (FBS), 20 ng/ml basic fibroblast growth factor (bFGF, Dong-A Pharmaceutical Co., Yongin, Korea) and N2 supplement (GIBCO, BRL, Grand Island, NY) in the atmosphere of 5% CO2 and 95% air at 37 o C. Medium was changed twice a week. Hepatocyte growth factor (HGF, a kind gift from Dr. JH Lee, Ajou Univ., Korea) was added to the culture to a final concentration of 10 ng/ml instead of bFGF. To determine the effect of PKA, forskolin (Sigma, St. Louis, MO) was added to the cells to a final concentration of 30 mM in DMEM/F12 (1:1) containing 0.5% FBS and N2 supplement.
RT-PCR
Total RNA was prepared from cells after differentiation using RNAZol-B solution (Tel-Test Inc., Friendswood, TX) according to the recommendations of manufacturer. Superscript kit (Invitrogen, Rockville, MD) was used for cDNA synthesis. The PCR reactions were carried out according to standard protocols. Primer sequences (forward and backward) and product sizes (base pairs) were as follows: human nestin (5' GGCAGCGTTGGAACAGAGGTTGGA 3', 5' CTCTAAACTGGAGTGGTCAGGGCT 3', 718 bp), human GFAP(5' GAGTCGCTGGAGGAGGAGATC 3', 5' GGGACTCGTTCGTGCCGCGC 3', 345 bp), human NSE (5' AAGGACAAATACGGCAAGGA 3', 5' TGGAC CAGGCAGCCCAATC 3', 328 bp), human NF-L (5' TCCTACTACACCATCCATGT 3', 5' TCCCCAGCACC TTCAACTTT 3', 285 bp) and human GAPDH (5' CC ACAGTCCATGCCATCACT 3', GAGCTTGACAAAGT GGTCGT 3', 403 bp).
Im m unocytochem istry
After treatment of forskolin for 1 week, neurocytoma cells were fixed with PBS containing 4% paraformaldehyde. The fixed cells were incubated with 5% normal horse serum followed by incubation with anti-nestin antibody (monoclonal, 1:100, Chemicon, Temecula, CA), anti-GFAP antibody (monoclonal, 1:200, Sigma, St. Louis, MO) or anti-b-tubulin III antibody (monoclonal, 1:500, Babco, Richmond, CA) overnight at 4 o C. After sufficient washing with PBS containing 0.01% triton X-100, cells were incubated with FITC conjugated anti-mouse IgG (1:200, Vector, Burlingame, CA) for one hour at room temperature. Immunoreactivity was detected with a fluorescence microscope.
R esults
Central neurocytom a cells express nestin Dissociated cells from neurocytoma cells were originally plated on DMEM/F12 (1:1) containing 2% FBS and subsequently kept in the presence of bFGF and N2 supplement. The cells exhibited a round cell body with bipolar or multipolar processes ( Figure 1A ). It has been previously reported that neurocytoma cells isolated from Japanese patients could be differentiated to neuronal cells and glial cells in vitro (Ishiuchi et al., 1998) . To characterize multipotency of neurocytoma cells, the expression level of the nestin gene was determined. Nestin is a class VI intermediate filament proteins and a well-known marker for stem cells in the nervous system (Andressen et al., 2001; Kawaguchi et al., 2001) . Total RNA was isolated from neurocytoma cells grown in the presence of bFGF and carried out RT-PCR. The primers were designed to span the exons 1 and 2 of the nestin gene to eliminate contamination of genomic DNA. The nestin cDNA was amplified as a 718 bp, indicating that neurocytoma cells contain neural stem cells ( Figure 1B) . Neurocytom as proliferate in response to bFG F Neural stem cells can form neurospheres in the presence of bFGF in serum free media (Chiasson et al., 1999; Ciccolini et al., 2001) . However, we were unable to obtain neurospheres from neurocytoma cells in the presence of bFGF in serum free medium. Instead, 20 ng/ml bFGF facilitated proliferation of neurocytoma cells in DMEM/F12 (1:1) containing 2% FBS and N2 (Figure 2) . Also, HGF known to facilitate regeneration of damaged tissues (Matsumoto and Nakamura, 1997; Ohmichi et al., 1998) increased growth of neurocytoma cells (Figure 2) . The data suggest that neurocytoma cells are similar to neural stem cells in terms of responsiveness to bFGF.
The effect of forskolin on differentiation of neurocytom a cells
Activation of cAMP dependent protein kinase A (PKA) has been known to cause various effects on differentiation in neural precursor cells. To determine the effect of PKA, forskolin was added to a final concentration of 30 mM to neurocytoma cells for a week. Before treatment of forskolin, neurocytoma cells exhibited a round cell body with bipolar or multipolar processes ( Figure 3A) . Treatment of forskolin induced morphological changes so that the cells outgrew processes ( Figure 3A) . To determine whether morphological changes accompanied expression of specific markers for astrocytes or neurons, total RNA was isolated from neurocytoma cells before and after treatment of forskolin and RT-PCR was carried out for the presence of nestin, GFAP, neurofilament-L (NF-L) and NSE. Interestingly, the expression level of GFAP was increased by forskolin, whereas expression of the nestin and NF-L genes was decreased ( Figure 3B ), indicating that neurocytoma cells lost neural stem cell properties and adopted an astrocyte fate. During the procedure, the expression level of NSE was not significantly altered. To confirm induction of astroglial differentiation of neurocytoma by forskolin, immunocytochemistry was carried out with antibodies against nestin, GFAP, and b-tubulin III (Figure 4) . Forskolin reduced the number of nestin-positive cells but increased the GFAP-positive cells. In contrast, the number of b-tubulin III positive cells was not significantly altered by the forskolin treatment. The consistent data obtained by RT-PCR analysis and immunocytochemistry suggest that neurocytoma cells can differentiate into astrocytes by the treatment of forskolin.
D iscussion
In this study, neurocytoma cells were shown to proliferate in response to bFGF and express the nestin gene in the proliferating condition with a minimum expression of NF-L and GFAP. Treatment of forskolin was found to increase expression of GFAP, an astrocyte marker with a concomitant decrease in expression of nestin and NF-L. Neural stem cells are categorized by self-renewing ability in response to bFGF and expression of the nestin gene (Tropepe et al., 1999) . The neurocytoma cells isolated from Korean patients highly proliferate in the presence of bFGF (Figure 2 ) and express the nestin gene. These data indicate that neurocytoma cells may have properties of neural progenitors or neural stem cells. Importantly, the nestin expression decreases when the cells undergo glial differentiation after treatment of forskolin ( Figure 3B ). It should be however, also noted that in the presence of bFGF, neurocytoma cells cannot form neurospheres in the serum free condition, which is the hallmark of neural stem cells (data not shown).
Activation of the PKA signaling pathway has phenotypic effects on differentiation of neural precursor cells. In this study, forskolin increases GFAP expression in neurocytoma cells while repressing expression of NF-L ( Figure 3B ). Increment of GFAP expression was also confirmed by immunocytochemistry at the expense of nestin (Figure 4 ). Neurocytoma cells already express b-tubulin III, an early neuronal marker (Svendsen et al., 2001) , and treatment with forskolin does not further increase it. Thus, the effect of forskolin is specific to astroglial differentiation.
PKA signaling pathway evoked by forskolin or cAMP can play a key role in differentiation of neural precursor cells. In neuroblastoma cells, forskolin or cell permeable analogues of cAMP cause neuronal differentiation including neurite outgrowth and expression of neuron specific genes (Bouron et al., 1999; Ghil et al., 2000; De Jonge et al., 2001; Kim et al., 2002) . On the contrary, cAMP increases glial differentiation in primary cultures of cells isolated from developing rat cortex (McManus et al., 1999; Grimaldi, 1999) . Although astroglial differentiation of neurocytoma cells has been previously reported after longterm culture (Westphal et al., 1994; Ishiuchi et al., 1998; Westphal et al., 1998) , the effect of forskolin was first demonstrated in neurocytoma cells in this study.
In summary, we demonstrated that neurocytoma cells isolated from Korean patients have self-renewing properties in response to bFGF similar to nestinpositive neural stem cells and activation of PKA pathway induce the cells to adopt an astrocyte cell fate. Thus, studies with neurocytoma may provide a useful tool to study how genetic and epigenetic program regulates neuronal and glial differentiation in human progenitor cells and to understand how abnormal regulation of proliferation leads to tumor. 
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